Aduhelm

Aducanumab, sold under the brand name Aduhelm, is a medication designed to treat Alzheimer's disease (AD).[1][2] It is an amyloid beta-directed monoclonal antibody[1][2] that targets aggregated forms of amyloid beta (Aβ) found in the brains of people with Alzheimer's disease to reduce its buildup.[3][4] Aducanumab was approved for medical use in the United States by the Food and Drug Administr... [wikipedia]